Endocrinology, Vol 128, 2895-2900, Copyright © 1991 by Endocrine Society

ARTICLES

Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone

TL McCarthy, M Centrella, LG Raisz and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.

Prostaglandin E2 (PGE2) affects both bone resorption and formation, but its mechanism of action remains unclear. PGE2 is known to elevate intracellular cAMP levels in a variety of culture systems. Agents that increase cAMP in primary osteoblast-enriched (Ob) cultures enhance the synthesis of skeletal insulin-like growth factor I (IGF-I), a potent anabolic factor for bone. A 5 min exposure to PGE2 at 0.01-1 microM enhanced cAMP synthesis in Ob cultures by 8- to 54-fold, and within 6 h produced up to a 3- fold increase in steady state prepro-IGF-I transcripts. The stimulatory effect of PGE2 on IGF-I messenger RNA was first evident within 4 h of treatment and remained elevated for at least 24 h. Furthermore, 0.01-1 microM PGE2 increased immunoreactive IGF-I polypeptide accumulation by 1.9- to 4.7-fold. In contrast PGE2 did not elevate steady state IGF-II mRNA or polypeptide levels within this time frame. Although PTH increase cAMP, intracellular calcium, and PGE2 production by bone cells, our previous studies indicate that the stimulatory effect of PTH on IGF-I production is cAMP, but not calcium dependent. Inhibition of PGE2 synthesis by exposure to indomethacin did not alter basal or PTH-stimulated IGF-I levels, substantiating that the effect of PTH on IGF-I is not PGE2 dependent. These studies indicate that PGE2 production, a feature common to many agents that enhance bone resorption, could contribute to the coupling of bone resorption and new bone formation, by way of its ability to increase cAMP and, consequently, IGF-I synthesis by the osteoblast.

This article has been cited by other articles:

				S. W. Donahue, S. A. Galley, M. R. Vaughan, P. Patterson-Buckendahl, L. M. Demers, J. L. Vance, and M. E. McGee Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis J. Exp. Biol., May 1, 2006; 209(9): 1630 - 1638. [Abstract] [Full Text] [PDF]

				D Lajeunesse, J Martel-Pelletier, J C Fernandes, S Laufer, and J-P Pelletier Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis Ann Rheum Dis, January 1, 2004; 63(1): 78 - 83. [Abstract] [Full Text] [PDF]

				C. Ji, W. Chang, M. Centrella, and T. L. McCarthy Activation Domains of CCAAT Enhancer Binding Protein {delta}: Regions Required for Native Activity and Prostaglandin E2-Dependent Transactivation of Insulin-Like Growth Factor I Gene Expression in Rat Osteoblasts Mol. Endocrinol., September 1, 2003; 17(9): 1834 - 1843. [Abstract] [Full Text] [PDF]

				F. W. Booth, M. V. Chakravarthy, S. E. Gordon, and E. E. Spangenburg Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy J Appl Physiol, July 1, 2002; 93(1): 3 - 30. [Abstract] [Full Text] [PDF]

				R. Kooijman, A. Coppens, and E. Hooghe-Peters IGF-I Inhibits Spontaneous Apoptosis in Human Granulocytes Endocrinology, April 1, 2002; 143(4): 1206 - 1212. [Abstract] [Full Text] [PDF]

				B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert Omega-3 Polyunsaturated Fatty Acids and Skeletal Health Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497. [Abstract] [Full Text] [PDF]

				B. A. Watkins and M. F. Seifert Conjugated Linoleic Acid and Bone Biology J. Am. Coll. Nutr., August 1, 2000; 19(4): 478S - 486. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts Endocrinology, January 1, 2000; 141(1): 127 - 137. [Abstract] [Full Text] [PDF]

				Y. Umayahara, J. Billiard, C. Ji, M. Centrella, T. L. McCarthy, and P. Rotwein CCAAT/Enhancer-binding Protein delta  Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts J. Biol. Chem., April 9, 1999; 274(15): 10609 - 10617. [Abstract] [Full Text] [PDF]

				U. Salli, F.F. Bartol, A.A. Wiley, B.J. Tarleton, and T.D. Braden Keratinocyte Growth Factor Expression by the Bovine Corpus Luteum Biol Reprod, July 1, 1998; 59(1): 77 - 83. [Abstract] [Full Text]

				C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]

				C. M. Veldman, I. Schlapfer, and C. Schmid Prostaglandin E2 Stimulates Sodium-Dependent Phosphate Transport in Osteoblastic Cells via a Protein Kinase C-Mediated Pathway Endocrinology, January 1, 1998; 139(1): 89 - 94. [Abstract] [Full Text] [PDF]

				Y. Umayahara, C. Ji, M. Centrella, P. Rotwein, and T. L. McCarthy CCAAT/Enhancer-binding Protein delta  Activates Insulin-like Growth Factor-I Gene Transcription in Osteoblasts. IDENTIFICATION OF A NOVEL CYCLIC AMP SIGNALING PATHWAY IN BONE J. Biol. Chem., December 12, 1997; 272(50): 31793 - 31800. [Abstract] [Full Text] [PDF]

				J. H. Shin, C. Ji, S. Casinghino, T. L. McCarthy, and M. Centrella Parathyroid Hormone-related Protein Enhances Insulin-like Growth Factor-I Expression by Fetal Rat Dermal Fibroblasts J. Biol. Chem., September 19, 1997; 272(38): 23498 - 23502. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF]

				B. A. Watkins, C.-L. Shen, J. P. McMurtry, H. Xu, S. D. Bain, K. G. D. Allen, and M. F. Seifert Dietary Lipids Modulate Bone Prostaglandin E2 Production, Insulin-Like Growth Factor-I Concentration and Formation Rate in Chicks J. Nutr., June 1, 1997; 127(6): 1084 - 1091. [Abstract] [Full Text]

				M. J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T. L. McCarthy Identification of the cAMP Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts J. Biol. Chem., September 6, 1996; 271(36): 21835 - 21841. [Abstract] [Full Text] [PDF]

				Y. Gu and S. J. Publicover Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts. CROSS-TALK WITH N-METHYL-D-ASPARTATE RECEPTORS J. Biol. Chem., October 27, 2000; 275(44): 34252 - 34259. [Abstract] [Full Text] [PDF]

				J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T. L. McCarthy, and P. Rotwein Regulated Nuclear-Cytoplasmic Localization of CCAAT/ Enhancer-binding Protein delta in Osteoblasts J. Biol. Chem., April 27, 2001; 276(18): 15354 - 15361. [Abstract] [Full Text] [PDF]

				J. Billiard, S. S. Grewal, L. Lukaesko, P. J. S. Stork, and P. Rotwein Hormonal Control of Insulin-like Growth Factor I Gene Transcription in Human Osteoblasts. DUAL ACTIONS OF cAMP-DEPENDENT PROTEIN KINASE ON CCAAT/ENHANCER-BINDING PROTEIN delta J. Biol. Chem., August 10, 2001; 276(33): 31238 - 31246. [Abstract] [Full Text] [PDF]

				B. Fournier, S. Gutzwiller, T. Dittmar, G. Matthias, P. Steenbergh, and P. Matthias Estrogen Receptor (ER)-alpha , but Not ER-beta , Mediates Regulation of the Insulin-like Growth Factor I Gene by Antiestrogens J. Biol. Chem., September 14, 2001; 276(38): 35444 - 35449. [Abstract] [Full Text] [PDF]